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Objective. The aim of this study was to investigate the role of hyperlipidemia in the microstructure of parotid gland and its
possible amelioration through statin treatment on Wistar rats. Methods. Forty Wistar rats (111.06 ± 3.36g) were divided into
4 groups (A1, A2 controls, B1, B2 experimental). Groups A1 and A2 consumed normal cereal rodents diet during the experimental
hyperlipidemic mixture. The A2 and B2 were treated with simvastatin (Zocor) 40mg/kg/daily p.o. for 3 months. Results.T o t a l
cholesterol, triglycerides, high density lipoproteins, and low density lipoproteins were increased in groups B1 and B2 while the
parotid weight was decreased. The histological ﬁndings demonstrated changes in the parotid gland morphology of the B1 and B2,
such as the presence of chronic inﬂammation, ﬁbrosis, lipocytes, and foci of lymphocytic inﬁltration. Conclusions. The inﬂuence
of statin tended to predominate over the chronic inﬂammation while the lipocytes were decreased and remodelling of the parotid’s
structure occurred.
1.Introduction
Hyperlipidemia is characterized by elevated levels of plasma
total cholesterol (TC), triglycerides (TG), and low-density
lipoprotein cholesterol (LDLC) [1, 2]. Patients with hyper-
lipidemia are considered to be at high risk to develop lipids
disorders that are associated with immune system deﬁciency,
promoting manifestations including fatty degeneration of
parotid parenchyma and parotid duct enlargement [3–6].
Various diseases could be associated with parotid gland
swelling, such as primary or secondary Sjogren Syndrome
(SS), diabetes mellitus, Wegener’s granulomatosis, sialadeni-
tis, and infections [7–9].
Recent studies have revealed that patients with SS and
treated for hyperlipidemia may present a resolution of
parotid symptoms [10]. Few clinical studies demonstrated
that children and adolescents with hypercholesterolemia
present endothelial disfunction [11, 12]. Simvastatin reduc-
ing TC and LDL-C concentrations restores endothelial func-
tionduringashortperiodoftime[11,12].Statinbeneﬁtsare
derivedfromreductionsinatherogeniclipoproteinlevelsand
increases in high-density lipoprotein cholesterol (HDL-C),
[13, 14].
Abnormal fat deposition in the major salivary glands
such as parotid gland could be detected by using short-
inversion-time inversion recovery (STIR) and fat-saturation
MR sequences and CT values. All three in vivo techniques
conﬁrm premature deposition of fat in the major salivary
glandswhiletheseverityoffatdepositioncouldbecorrelated
with impaired rates of salivary ﬂow in these patients [15–17].
MR imaging ﬁndings of salivary glands in patients with
hyperlipidemia include enlargement of parotid gland, lipid
inﬁltration, and impaired salivary ﬂow, whereas sialography
of parotid gland revealed normal ﬁndings [15–17]. Moni-
toring of fat deposition might be a very useful weapon in
diagnosis any parotid gland’s disease [15–18].
The aim of this study was to investigate the role of
hyperlipidemia in the parotid gland’s microstructure of
Wistar rats and the inﬂuence of simvastatin treatment.2 International Journal of Dentistry
2.MaterialsandMethods
Forty female, speciﬁc–pathogen-free Wistar rats aged
8–10weeks (mean body weight 111.06 ± 3.36g) were used
and divided into the following four groups:
A1 control: normal cereal rodents diet (n = 10),
A2 control: normal cereal rodents diet (n = 10),
B1 experimental: special diet (n = 10),
B2 experimental: special diet (n = 10).
Groups B1 and B2 were treated with high fat diet
in order to investigate its inﬂuence in rats (group B1).
Normal cereal rodents’ diet contained 100% cereals while
hyperlipidemic diet consisted of 50% cereals, 20% butter,
10.5% sucrose, 10% casein, 2.5% cholesterol, 1% vitamins,
0.15% propylthiouracil and 0.1% choline [19]. Moreover,
groups A2 and B2 received simvastatin (Zocor was gratefully
oﬀered by Vianex) 40mg/kg/daily peros for 3months via
gastroesophageal cathether.
The animal experiment was performed in accordance
withtheinstitutionalandnationalguidelinesforthecareand
the use of experimental animals and, therefore, in compli-
ance with the European Communities Council Directive of
24 November 1986 [20] .A l la n i m a l sw e r es a c r i ﬁ c e du n d e r
general anaesthesia and blood samples from carotid vessel
were collected in order to examine the serum lipids such as
TC,HDL,LDL,andTG.Parotidglandwasisolated,removed,
and examined. The purpose was to notify any diﬀerence in
the organs’ macro and microstructure. The parotid glands
were preserved in 10% buﬀered formaldehyde ﬁxative solu-
tion (Merck) for further histological examination. Sections
of parotids’ specimens were stained with haematoxylin-
oesin, and a full histological investigation was carried out.
Furthermore,themorphometricsfeatureswereevaluated
using a microscope Bx42 Olympus, a camera Altra 20 Olym-
pus, and image’s analysis with Image —Pro Plus. Moreover,
basedonthemorphometricﬁndings,astatisticalanalysiswas
performed using Excel-Student t-test. Biochemical features
were statistically analyzed by performing SPSS Kruskal-
Wallis Test and Mann-Whitney Test.
3. Results
3.1. Laboratory Findings. The hyperlipidemic diet in group
B1 leads to a statistically signiﬁcant increase of TC, HDL,
HDL, and TG (P<. 001) and to an insigniﬁcant increase of
parotid gland weight compared to group A1 (normal cereal
diet) and A2 (normal cereal diet + simvastatin), (Table 1).
Furthermore, the simvastatin treatment in group B2
(hyperlipidemic diet + simvastatin) compared to group B1
decreasedtheserumlevelsof TC,HDL,LDL,TGand parotid
gland in a statistically signiﬁcant way (P<. 001), (Table 1).
No changes were observed in group A2 compared to
group A1 concerning the serum lipids proﬁle and the parotid
gland weight (Table 1). Group A2 presented a statistically
insigniﬁcant decrease of parotid gland weight compared to
group B1 and group B2 (Table 1). Group B2 in comparison
to group A2 the serum levels of TC, HDL, LDL, TG, and
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Figure 1: In group B1, lipid inﬁltration of the parotid parechyma,
presence of lipocytes and nuclei abnormalities (increased cell area
and duct’s diameter, decreased duct’s number) were observed
(haematoxylin eosin— original magniﬁcation ×400).
liver weight were increased in a statistically signiﬁcant way
(P<. 001), (Table 1).
Finally, as far as the atheromatic index in group B1 and
group B2 was concered, it should be underlined that there
was a statistically insigniﬁcant diﬀerence (Table 1).
3.2. Histological Findings via Morphometry. According to
histological ﬁndings, diﬀerent state of lipid inﬁltration of the
parotid gland specimens, stained with haematoxylin-oesin,
in hyperlipidemic animals in group B1, B2 was observed. In
addition, chronic inﬂammation, mild ﬁbrosis, lypocytes, foci
oflymphocyticinﬁltrationnucleiabnormalitiesanddiversity
of vessel wall thickness were recorded [4, 18].
Moreover, based on the morphometrical analysis of the
histological features, our research resulted in the following
discoveries:
(a) Animals of group B1 compared to animals of group
A1,demonstratedastatisticallysigniﬁcantincreaseof
cell area and duct’s diameter while the duct’s number
was decreased (P<. 001, Figure 1, Table 2).
(b) Animals of group B2 compared to animals of group
A1, revealed statistically insigniﬁcant alterations in
the cell area, the number and diameter of the ducts
(P>. 01, Figure 2, Table 2).
3.3. Discussion. The goal of this research was to evaluate the
microstructural alterations of parotid gland in experimental
hyperlipidemia and the possible amelioration through statin
treatment in Wistar rats. According to the biochemical data
hyperlipidemic diet leads to an elevated serum lipid proﬁle
that might be responsible for parotid gland swelling as it
is referred from Goldman and Julian, Kaltreider and Talal,
Manganelli et al., and Tretbar [3, 4, 6, 19]. In addition,
Izumi et al. suggest that parotid gland is more aﬀected
by hyperlipidemia than submandibular gland [16, 17].International Journal of Dentistry 3
Table 1: Mean and standard deviation of mean of total cholosterol (TC), triglycerides (TG), high density lipoproteins (HDL), low -density
lipoproteins (LDL), parotid gland-liver-thymos-spleen-adrenal weight, and atheromatic index in the four groups (A1, A2, B1, B2).
Groups A1 A2 B1 B2
TC mg/dL 54.71 ±0.000
∗ 65.25 ±0.000
∗ 391.14 ±0.000
∗ 346.25 ± 0.000
∗
HDL mg/dL 17.09 ±0.000
∗ 20.12 ±0.000
∗ 40.86 ±0.000
∗ 36.37 ± 0.000
∗
LDL mg/dL 25.29 ±0.000
∗ 27.25 ±0.000
∗ 324.86 ±0.000
∗ 285.25 ±0.000
∗
TG mg/dL 62.29 ±0.000
∗ 89.12 ±0.000
∗ 128.00 ±0.000
∗ 123.00 ±0.000
∗
Parotid weight mg 37.80 ±2.208
∗∗∗ 39.57 ±6.607
∗∗∗ 43.71 ±2.556
∗∗∗ 35.84 ±3.568
∗∗∗
Atheromatic index 3.20 ±0.98
∗∗∗ 3.24 ±1.01
∗∗∗ 9.57 ±0.34
∗∗∗ 9.52 ±0.33
∗∗∗
∗P<. 001, ∗∗P<. 01, ∗∗∗P>. 01.
TC: A1/A2∗∗∗,A 1 / B 1 ∗,A 2 /B 1 ∗,A 2 / B 2 ∗,B 1 / B 2 ∗,A 1 / B 2 ∗.
HDL: A1/A2∗∗∗,A 1 / B 1 ∗,A 2 /B 1 ∗,A 2 / B 2 ∗,B 1 / B 2 ∗,A 1 / B 2 ∗.
LDL: A1/A2∗∗∗,A 1 / B 1 ∗,A 2 /B 1 ∗,A 2 / B 2 ∗,B 1 / B 2 ∗,A 1 / B 2 ∗.
TG: A1/A2∗∗∗,A 1 / B 1 ∗,A 2 /B 1 ∗,A 2 / B 2 ∗,B 1 / B 2 ∗,A 1 / B 2 ∗.
Parotid weight: A1/A2∗∗∗,A 1 / B 1 ∗∗∗,A 2 /B 1 ∗∗∗,A 2 / B 2 ∗∗∗,B 1 / B 2 ∗∗∗,A 1 / B 2∗∗∗.
Atheromatic index: A1/A2∗∗∗,A 1 / B 1 ∗∗∗,A 2 /B 1 ∗∗∗,A 2 / B 2 ∗∗∗,B 1 / B 2 ∗∗∗,A 1 / B 2 ∗∗∗.
Table 2: Item Measurement parameters (statistical average value) for cells and ducts in the four groups of animals.
Density (ave) Density (std) Diameter Ratios (PER area %) Aspect ratio
Cells
Group A1 74.621 7.248 5.589 7.154% 1.481
Group A2 71.890 6.969 5.663 9.409% 1.472
Group B1 76.413 7.722 6.658 5.660% 1.531
Group B2 78.066 7.950 5.877 12.361% 1.546
Ducts
Group A1 130.849 35.091 33.736 1.545% 1.281
Group A2 131.985 37.292 34.437 1.481% 1.301
Group B1 135.055 36.146 41.140 0.633% 1.218
Group B2 135.064 36.740 40.838 2.388% 1.369
Cell area
Figure 2: In group B2, there were not signiﬁcant alterations in the
cell area or the number and the diameter of the ducts of the parotid
gland (haematoxylin eosin—original magniﬁcation ×400).
The above results are in accordance with the ﬁndings of
Sheikh et al., suggesting a close relationship between parotid
gland swelling and high levels of triglycerides in plasma
[10, 16, 17].
Moreover, it is not well known how hyperlipidemia
causes parotid gland swelling. Larsson et al. used the
Folch method in order to extract the lipids from parotid,
submandibular,and whole stimulated saliva in human [21].
AccordingtoFolchetal.,inthismethod,thetissueishomog-
enized with Chloroform/methanol (2/1) to a ﬁnal volume 20
times the volume of the tissue sample and after dispersion
the whole mixture is agitated during 15–20minutes in a
orbital shaker at room temperature. The homogenate is
either ﬁltrated or centrifuged to recover the liquid phase.
The solvent is washed with 0.2 volumes (4mL for 20mL)
o fw a t e ro rb e t t e r0 . 9 %N a C ls o l u t i o n .A f t e rv o r t e x i n gs o m e
seconds, the mixture is centrifuged at low speed to separate
the two phases. After centrifugation and siphoning of the
upper phase, the lower chloroform phase containing lipids is
evaporated under vacuum in a rotary evaporator or under a
nitrogenstreamifthevolumeisunder2-3mL[22].Larsson’s
ﬁndings indicate that saliva lipids mainly consist of choles-
terol esters, cholesterol, triglycerides, diglycerides, mono-
glycerides, and free fatty acids [21]. According to Hindy et
al., the saliva gland parenchyma is considered to be a place of
sterols biosynthesis, similar to those of liver, as it was proven
by using thin-layer and gas-liquid chromatography [23].
Man et al. demonstrated changes of the pancreas mor-
phology by hypertriglyceridemia. It seems that triglycerides4 International Journal of Dentistry
(TGs)arestoredinpancreaticislets,whichinhibitedglucose-
induced insulin secretion, in part, via reduced glucokinase
activity in the islets [24]. Several studies have suggested that
pancreasandparotidglandmaypresent,inpart,morpholog-
ical and functional similarities [25–28]. Therefore, Anderson
et al. studied salivary tissues of diabetic male Wistar rats
in order to distinguish the diﬀerences in intracellular lipids
between diabetic and controls glands. Lipid accumulation
within parenchymal cells depended on the type of the gland
and their content of serous cells. Parotid and sublingual
glands possess the greatest amount of lipids compared to
submandibular gland. Their ﬁndings may explain the mild
alteration of the submandibular gland in patients with
hyperlipidemia contrary to the parotid gland’s involvement
[29].
Moreover, this report reveals that the hyperlipidemic
diet may result to no statistically signiﬁcant decrease of
parotidweight,observedinthehyperlipidemic-experimental
group compared to controls. It is of great interest that
hyperlipidemia, except for lipid deposition and lympho-
cytic inﬁltration of parotid gland, causes alterations of the
parenchyma as well.
Furthermore, simvastatin treatment resulted in a statisti-
cally signiﬁcant decrease of serum lipid proﬁle but to a statis-
tically insigniﬁcant decrease of parotid gland weight. Statins
seem to repair parotid gland’s changes caused by hyperlipi-
demia, resulting eventually to gland remodelling [11].
Due to our ﬁndings, a close relationship between high
plasma lipid levels and parotid gland enlargement may be
concluded. This enlargement might be an indication of
parotid gland’s microstructural changes, and it may explain
itxs observed, by other investigators, functional impairment.
It is obvious that statins, reducing the serum lipid proﬁle,
may play a protective role in organs’ injuries caused by
hyperlipidemia by repairing the occurred alterations.
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